2 weeks Ago By Defense World Staff
Norges Bank bought a new stake in shares of Bausch Health Companies Inc. ( NYSE:BHC – Free Report ) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 17,516 shares of the company’s stock, valued at approximately $141,000.
Several other large investors have also bought and sold shares of the stock. Geode Capital Management LLC boosted its holdings in Bausch Health Companies by 20.5% during the third quarter.
Geode Capital Management LLC now owns 636,082 shares of the company’s stock worth $6,448,000 after purchasing an additional 108,269 shares during the last quarter. Range Financial Group LLC purchased a new position in shares of Bausch Health Companies in the 4th quarter worth approximately $1,004,000. Sanders Morris Harris LLC grew its holdings in shares of Bausch Health Companies by 16.
0% in the fourth quarter. Sanders Morris Harris LLC now owns 28,975 shares of the company’s stock valued at $234,000 after acquiring an additional 4,000 shares in the last quarter. Merit Financial Group LLC bought a new position in shares of Bausch Health Companies in the fourth quarter valued at approximately $228,000.
Finally, SG Americas Securities LLC increased its position in shares of Bausch Health Companies by 62.0% during the fourth quarter. SG Americas Securities LLC now owns 3,301,981 shares of the company’s stock valued at $26,614,000 after acquiring an additional 1,263,706 shares during the last quarter.
78.65% of the stock is currently owned by institutional investors. Analyst Ratings Changes Several research analysts have weighed in on BHC shares.
Royal Bank of Canada cut their price objective on Bausch Health Companies from $9.00 to $8.50 and set a “sector perform” rating on the stock in a research report on Monday, April 7th.
Jefferies Financial Group reissued a “hold” rating and issued a $8.00 price target (down from $12.00) on shares of Bausch Health Companies in a report on Thursday, February 6th.
One investment analyst has rated the stock with a sell rating, six have issued a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $7.
17. Bausch Health Companies Stock Performance BHC stock opened at $4.33 on Friday.
Bausch Health Companies Inc. has a fifty-two week low of $3.96 and a fifty-two week high of $9.
85. The company has a market capitalization of $1.59 billion, a price-to-earnings ratio of -36.
04, a price-to-earnings-growth ratio of 0.37 and a beta of 0.43.
The business’s 50 day moving average price is $6.53 and its two-hundred day moving average price is $7.54.
Bausch Health Companies ( NYSE:BHC – Get Free Report ) last released its quarterly earnings results on Wednesday, February 19th. The company reported $1.21 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.
65 by ($0.44). Bausch Health Companies had a negative return on equity of 577.
82% and a negative net margin of 0.48%. The firm had revenue of $2.
56 billion during the quarter, compared to analysts’ expectations of $2.51 billion. Sell-side analysts forecast that Bausch Health Companies Inc.
will post 4.41 earnings per share for the current year. About Bausch Health Companies ( Free Report ) Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally.
It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. See Also Five stocks we like better than Bausch Health Companies What is diluted earnings per share (Diluted EPS)? Robinhood Strategies Could Be a Game-Changer for Young Investors What is a Bond Market Holiday? How to Invest and Trade Are These 3 Retail Stocks Oversold or Really in Trouble? What Makes a Stock a Good Dividend Stock? IONQ & RGTI Join DARPA Quantum Initiative: High Stakes Are Ahead Receive News & Ratings for Bausch Health Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch Health Companies and related companies with MarketBeat.com's FREE daily email newsletter .
.
